Trial Profile
BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon? by Using Elements of the BetaPlus Program
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2012
Price :
$35
*
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Bayer
- 15 Nov 2010 New trial record